Prostate cancer is a health issue that impacts individuals worldwide, and choosing the best treatment can be difficult, given ...

A new study has found that many cases of high-risk nonmetastatic hormone-sensitive prostate cancer may be more advanced than previously thought.

Advanced imaging reveals hidden metastases in high-risk prostate cancer cases, offering new insights for better diagnosis and treatment strategies.

A new study led by researchers at the UCLA Health Jonsson Comprehensive Cancer Center has found that many cases of high-risk nonmetastatic hormone-sensitive prostate cancer may be more advanced than ...

Researchers at UCLA have unveiled startling findings using PSMA-PET imaging that reveal nearly half of patients diagnosed ...

Amid rumors about Israeli PM Benjamin Netanyahu's prostate surgery, medical experts raise key questions about the procedure's ...

Oral estrogens were the treatment of choice for carcinoma of the prostate for over four decades ... which upregulates the hepatic metabolism of hormones, lipids and coagulation proteins.

Prostate cancer ranks among the most common health challenges men face worldwide. While medical advances continue to improve treatment outcomes, the e ...

Researchers found that prostate cancer patients with greater socioeconomic disadvantages were less likely to receive targeted therapy, and participation in the 340B program did not counteract that.

HRS-1167 is under clinical development by Merck and currently in Phase I for Castration-Resistant Prostate Cancer (CRPC).

Greater investments in ongoing clinical trials and oncology research encourage innovation in the treatment, thus boosting the ...